Feature | Stents Bioresorbable | April 13, 2016 | Dave Fornell
Bioresorbable stents have been one of the hottest new cardiovascular technologies discussed at cardiology meetings ov
Videos | Stents Bioresorbable | April 12, 2016
Gregg Stone, M.D., director of cardiovascular research and education at Columbia University Medical Center / New York
Feature | Stents Bioresorbable | March 15, 2016 | Dave Fornell
An independent panel of experts convened by the U.S. Food and Drug Administration (FDA) voted 9 to 0, with one...
News | Heart Valve Technology | February 29, 2016
February 29, 2016 — Abbott has initiated a voluntary safety notice regarding the...
News | Ablation Systems | February 02, 2016
Abbott announced that it has acquired private medical device company Kalila Medical Inc. Kalila Medical is a developer...
News | Cath Lab | January 20, 2016 | Dave Fornell
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel is set to review data and offer...
Videos | TCT | November 05, 2015
Tom Watson, clinical analyst for MDBuyLine, and DAIC Dave Fornell discuss some of the technology trends at the 2015 T
News | Stents Bioresorbable | October 30, 2015
October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable
Videos | Stents Bioresorbable | October 30, 2015
Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for
News | Stents Drug Eluting | October 23, 2015
Results of the TUXEDO trial, designed to compare two types of stents in diabetic patients, found paclitaxel-eluting...